Bariatric surgery is associated with significant reductions in the risks for any cancer and obesity-related cancer in nonalcoholic fatty liver disease patients with severe obesity.
Investigators summarized past and current research on the diagnosis and treatment of NASH to encourage development of noninvasive testing for the disease.
A team of investigators conducted a study to estimate the global prevalence of metabolic dysfunction-associated fatty liver disease in overweight and obese adults.
A team of investigators sought to better understand the interethnic clinical, biochemical, and histologic differences in the prevalence of NAFLD and NASH.
Researchers in a real-world clinical practice study assessed the incidence of weight loss and weight regain in patients with NAFLD and overweight or obesity.
A green-Mediterranean diet, enriched with green plants and polyphenols, can reduce intrahepatic fat loss more than other healthy eating plans.
A team of investigators conducted a retrospective review of records to determine the effect of gastric bypass surgery on patients with type 2 diabetes and comorbid liver steatosis.
A team of investigators sought to identify the accuracy of diagnostic tools for the detection of nonalcoholic fatty liver disease in adolescent patients.
The American Gastroenterological Association commissioned an expert review to identify best practice advice for treating patients with nonalcoholic fatty liver disease.
Investigators compared a carbohydrate-restricted diet with a low-calorie diet to determine which more effectively reduced hepatic triglyceride content in children with nonalcoholic fatty liver disease.
Investigators studied the risk of overall and cause-specific mortality across the histological spectrum in individuals with non-alcoholic fatty liver disease.
From 2009 to 2018, there was an increase in the incidence of nonalcoholic fatty liver disease among children, although many NAFLD cases remain undiagnosed.
Investigators studied the impact of changes in adiposity over patients’ life courses on the midlife development of nonalcoholic fatty liver disease.
Investigators sought to determine whether a very low-calorie diet is feasible and acceptable to achieve and maintain a weight loss of 10% or more in patients with nonalcoholic fatty liver disease.
The use of CPAP alone does not appear to improve hepatic steatosis and fibrosis in patients with nonalcoholic fatty liver disease and obstructive sleep apnea.
TERN-201 is a highly-selective semicarbazide-sensitive amino oxidase inhibitor.
The NIS4 biomarker panel may provide a means for clinicians to avoid unnecessary liver biopsies in patients at low risk for NASH.
A team of investigators studied the relationship between changes in liver histology and changes in body mass index, dyslipidemia, and measures of glucose homeostasis in children.
A systematic review and meta-analysis of observational studies was conducted to assess the prevalence of nonalcoholic fatty liver disease in the general population.
As the role of the gut microbiome in nonalcoholic fatty liver disease is explored, research has turned to fecal microbiota transplantation as a potential treatment option.